Leaflet PREOTACT 100mcg powder+solvent for injection
Indicated for: hypoparathyroidism
Route of administration: injectable
Substance: parathyroid hormone (thyroid hormone)
ATC: H05AA03 (Systemic hormonal preparations, excluding sex hormones and insulins | Parathyroid hormones and analogues)
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Parathyroid hormone (PTH) is used in the treatment of severe osteoporosis in patients at high risk of fractures. It stimulates bone formation by increasing osteoblast activity and improving calcium metabolism.
The medication is administered subcutaneously, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular tests to monitor bone health.
Patients should be aware of potential side effects, such as nausea, joint pain, or dizziness. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, joint pain, and dizziness. In rare cases, severe reactions such as hypercalcemia or allergic reactions may occur. Patients should be informed of these risks before use.
General data about PREOTACT 100mcg
- Substance: parathyroid hormone
- Date of last drug list: 01-07-2013
- Commercial code: W51659001
- Concentration: 100mcg
- Pharmaceutical form: powder+solvent for injection
- Quantity: 2
- Product type: original
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Pharmaceutical forms available for parathyroid hormone
Concentrations available for parathyroid hormone
- 100mcg
- 100mcg/dose
- 25mcg/dose
- 50mcg/dose
- 75mcg/dose